Ken Griffin’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $372M | Sell |
13,044,300
-6,038,400
| -32% | -$161M | 0.04% | 331 |
|
|
2026
Q2 | $460M | Buy |
19,082,700
+7,028,800
| +58% | +$184M | 0.05% | 260 |
|
|
2026
Q1 | $338M | Sell |
12,053,900
-6,876,000
| -36% | -$183M | 0.05% | 277 |
|
|
2025
Q4 | $471M | Buy |
18,929,900
+4,429,400
| +31% | +$112M | 0.07% | 202 |
|
|
2025
Q3 | $369M | Sell |
14,500,500
-1,476,700
| -9% | -$36.4M | 0.06% | 266 |
|
|
2025
Q2 | $387M | Sell |
15,977,200
-3,559,300
| -18% | -$83M | 0.07% | 210 |
|
|
2025
Q1 | $495M | Buy |
19,536,500
+1,204,000
| +7% | +$31.5M | 0.09% | 130 |
|
|
2024
Q4 | $486M | Sell |
18,332,500
-6,494,100
| -26% | -$176M | 0.08% | 150 |
|
|
2024
Q3 | $718M | Sell |
24,826,600
-4,764,000
| -16% | -$139M | 0.14% | 86 |
|
|
2024
Q2 | $828M | Buy |
29,590,600
+1,022,900
| +4% | +$28.2M | 0.17% | 74 |
|
|
2024
Q1 | $793M | Buy |
28,567,700
+7,386,400
| +35% | +$205M | 0.15% | 75 |
|
|
2023
Q4 | $610M | Buy |
21,181,300
+2,295,400
| +12% | +$69.4M | 0.12% | 89 |
|
|
2023
Q3 | $626M | Buy |
18,885,900
+1,480,400
| +9% | +$52.4M | 0.13% | 74 |
|
|
2023
Q2 | $638M | Buy |
17,405,500
+9,277,000
| +114% | +$361M | 0.13% | 74 |
|
|
2023
Q1 | $332M | Sell |
8,128,500
-5,171,300
| -39% | -$223M | 0.07% | 172 |
|
|
2022
Q4 | $681M | Buy |
13,299,800
+5,719,400
| +75% | +$274M | 0.16% | 70 |
|
|
2022
Q3 | $332M | Buy |
7,580,400
+203,300
| +3% | +$9.9M | 0.08% | 165 |
|
|
2022
Q2 | $387M | Sell |
7,377,100
-2,537,400
| -26% | -$129M | 0.1% | 123 |
|
|
2022
Q1 | $513M | Buy |
9,914,500
+2,031,300
| +26% | +$105M | 0.11% | 104 |
|
|
2021
Q4 | $466M | Sell |
7,883,200
-2,684,800
| -25% | -$133M | 0.1% | 123 |
|
|
2021
Q3 | $455M | Buy |
10,568,000
+2,717,100
| +35% | +$120M | 0.09% | 134 |
|
|
2021
Q2 | $307M | Sell |
7,850,900
-4,451,000
| -36% | -$173M | 0.07% | 191 |
|
|
2021
Q1 | $446M | Sell |
12,301,900
-365,100
| -3% | -$13M | 0.11% | 102 |
|
|
2020
Q4 | $466M | Buy |
12,667,000
+6,267,200
| +98% | +$230M | 0.12% | 96 |
|
|
2020
Q3 | $235M | Buy |
6,399,800
+2,351,500
| +58% | +$86.9M | 0.07% | 159 |
|
|
2020
Q2 | $132M | Buy |
4,048,300
+244,900
| +6% | +$8.77M | 0.05% | 300 |
|
|
2020
Q1 | $124M | Buy |
3,803,400
+134,600
| +4% | +$4.83M | 0.06% | 266 |
|
|
2019
Q4 | $144M | Sell |
3,668,800
-716,600
| -16% | -$26.9M | 0.06% | 269 |
|
|
2019
Q3 | $158M | Buy |
4,385,400
+1,950,600
| +80% | +$74.8M | 0.07% | 220 |
|
|
2019
Q2 | $105M | Sell |
2,434,800
-267,000
| -10% | -$11.2M | 0.05% | 381 |
|
|
2019
Q1 | $115M | Buy |
2,701,800
+971,900
| +56% | +$41M | 0.06% | 311 |
|
|
2018
Q4 | $75.5M | Buy |
1,729,900
+503,200
| +41% | +$22M | 0.04% | 433 |
|
|
2018
Q3 | $54.1M | Sell |
1,226,700
-174,800
| -12% | -$7.09M | 0.02% | 719 |
|
|
2018
Q2 | $50.8M | Buy |
1,401,500
+333,600
| +31% | +$12M | 0.03% | 695 |
|
|
2018
Q1 | $37.9M | Sell |
1,067,900
-160,000
| -13% | -$5.8M | 0.02% | 734 |
|
|
2017
Q4 | $44.5M | Buy |
1,227,900
+138,600
| +13% | +$4.98M | 0.03% | 677 |
|
|
2017
Q3 | $38.9M | Sell |
1,089,300
-24,100
| -2% | -$816K | 0.03% | 674 |
|
|
2017
Q2 | $37.4M | Sell |
1,113,400
-509,400
| -31% | -$16.9M | 0.03% | 635 |
|
|
2017
Q1 | $55.5M | Sell |
1,622,800
-742,400
| -31% | -$24.7M | 0.05% | 399 |
|
|
2016
Q4 | $76.8M | Buy |
2,365,200
+893,100
| +61% | +$28.7M | 0.08% | 231 |
|
|
2016
Q3 | $49.9M | Sell |
1,472,100
-787,900
| -35% | -$27.8M | 0.05% | 384 |
|
|
2016
Q2 | $79.6M | Buy |
2,260,000
+386,800
| +21% | +$13M | 0.09% | 194 |
|
|
2016
Q1 | $55.5M | Buy |
1,873,200
+1,036,700
| +124% | +$31.2M | 0.07% | 265 |
|
|
2015
Q4 | $27M | Sell |
836,500
-216,200
| -21% | -$7.17M | 0.03% | 671 |
|
|
2015
Q3 | $33.1M | Buy |
1,052,700
+279,300
| +36% | +$9.44M | 0.03% | 609 |
|
|
2015
Q2 | $25.9M | Buy |
773,400
+186,100
| +32% | +$6.39M | 0.02% | 843 |
|
|
2015
Q1 | $20.4M | Sell |
587,300
-227,800
| -28% | -$7.63M | 0.02% | 970 |
|
|
2014
Q4 | $25.4M | Buy |
815,100
+116,800
| +17% | +$3.53M | 0.03% | 803 |
|
|
2014
Q3 | $20.6M | Sell |
698,300
-71,500
| -9% | -$2.12M | 0.02% | 895 |
|
|
2014
Q2 | $22.8M | Sell |
769,800
-214,100
| -22% | -$6.43M | 0.03% | 734 |
|
|
2014
Q1 | $31.6M | Sell |
983,900
-54,300
| -5% | -$1.71M | 0.04% | 583 |
|
|
2013
Q4 | $31.8M | Buy |
1,038,200
+210,000
| +25% | +$6.44M | 0.04% | 561 |
|
|
2013
Q3 | $23.8M | Buy |
828,200
+66,500
| +9% | +$1.91M | 0.04% | 641 |
|
|
2013
Q2 | $21.3M | Hold |
761,700
| – | – | 0.04% | 629 |
|
Other funds holding PFE
Ken Griffin's PFE Position: Q3 2026 in Review
Ken Griffin reduced its Pfizer (PFE) stake by 23% in Q3 2026, selling an estimated $38.6M and leaving 4,741,501 shares worth $135M. The position accounts for 0.02% of the portfolio, ranked #795.
Ken Griffin first reported a position in PFE in Q2 2013 and has held it in 54 quarters since. The position peaked at $571M in Q2 2024. 2,918 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Ken Griffin held 4,741,501 shares of Pfizer worth $135M as of Q3 2026.
- Ken Griffin sold 1,449,685 Pfizer shares in Q3 2026, an estimated $38.6M.
- Pfizer made up 0.02% of Ken Griffin's portfolio in Q3 2026, its #795 holding.
- Ken Griffin first reported a position in Pfizer in Q2 2013 and has held it in 54 quarters since.
- Ken Griffin's Pfizer position peaked at $571M in Q2 2024.
- 2,918 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.